Efficacy and Safety of High-Dose Rifampicin in the Management of Tuberculosis Meningitis: A Systematic Review and Meta-Analysis
Abstract
Tuberculosis meningitis (TBM) represents the most severe type of tuberculosis (TB), and it is characterized by high mortality and neurological complications. Rifampicin is a major part of the standard treatment of TB; however, conventional doses often achieve subtherapeutic levels in the central nervous system. High-dose rifampicin has been suggested to enhance drug exposure and, possibly, improve the clinical outcomes. This study is a systematic review and meta-analysis evaluating the effectiveness and safety of high-dose rifampicin compared with standard-dose rifampicin in the treatment of TBM. PubMed, the Cochrane Library, and ScienceDirect were searched to identify randomized controlled trials (RCTs) published between 2010 and 2026. The included studies involved adult patients with TBM receiving either high-dose or standard-dose rifampicin. Pharmacokinetic results and risk ratios (RR) were estimated using a random-effects model with data pooling to estimate mean differences (MD) and confidence intervals (CI). Eight RCTs were included. The maximum plasma concentration (Cmax) (MD 23.89 µg/mL; 95% CI (8.56, 39.21)) and total drug exposure (AUC(0-24)) (MD 148.66 µg·h/mL; 95% CI (19.38, 277.94)) were both found to be significantly higher with high-dose rifampicin compared to standard-dose rifampicin. No significant difference, however, was found in six-month mortality (RR 1.00; 95% CI (0.80, 1.26)). The risk of neurological adverse events was higher with high-dose rifampicin…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.